The Project Genome stock research hasn't been perfect, not by a long shot. When I search for a stock, the latest update is usually several months old. Still, even old research is better than nothing.
But what I loved about their research was the commentary, which was very straightforward. They were brutally frank about a movie's prospects. An indie comedy with no stars? OK, that would be a short. An IPO of a movie that's already wrapped production? Hello and goodbye - short short short. On the other hand, I remember the description of a blockbuster, I think one of the Spiderman movies, as having a release pattern "wider than the widest river at it widest point" (or something like that).
In July of 2007, they wrote this about Delgo:
the stock will hang around HSX like a bad smell as long as there’s the slightest chance of it being released. Let’s all hope for a quick STDVD release.That was exactly what happened - it hung around like a bad smell. They knew a long time ago that it was a dog, and they were right. It delisted at H$0.51.
I applied for a position at HSBR a long time ago. I obviously didn't get it, but I think it worked out for all concerned. The person who did get the gig, Ultimate Frisbee, married one of the other people on the site. And I would have had to resign after getting into USC. But I still miss HSBR, and I'll miss Project Genome. One thing I miss the most about HSBR is the weekly predictions. I am trying to fill in the gap just a little bit with my own predictions, but I can't begin to hope to fill the shoes of the entire HSBR crew.
So thanks, Blue Duck, for all your hard work over the years, thanks in advance for keeping the bond charts going, and here's hoping that Project Genome is somehow, maybe, just maybe, resurrected once again.